1. Home
  2. ESPR vs CCNE Comparison

ESPR vs CCNE Comparison

Compare ESPR & CCNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$2.64

Market Cap

731.9M

Sector

Health Care

ML Signal

HOLD

Logo CNB Financial Corporation

CCNE

CNB Financial Corporation

HOLD

Current Price

$28.43

Market Cap

818.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESPR
CCNE
Founded
2008
1865
Country
United States
United States
Employees
N/A
950
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
731.9M
818.2M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
ESPR
CCNE
Price
$2.64
$28.43
Analyst Decision
Strong Buy
Buy
Analyst Count
5
2
Target Price
$7.60
$32.00
AVG Volume (30 Days)
5.0M
143.1K
Earning Date
03-10-2026
04-15-2026
Dividend Yield
N/A
2.54%
EPS Growth
60.71
N/A
EPS
N/A
N/A
Revenue
$403,135,000.00
N/A
Revenue This Year
$2.92
$23.21
Revenue Next Year
N/A
$7.00
P/E Ratio
N/A
$11.84
Revenue Growth
21.31
N/A
52 Week Low
$0.73
$19.32
52 Week High
$4.18
$30.84

Technical Indicators

Market Signals
Indicator
ESPR
CCNE
Relative Strength Index (RSI) 42.52 53.68
Support Level $2.37 $23.52
Resistance Level $3.02 $30.57
Average True Range (ATR) 0.18 0.68
MACD 0.04 0.12
Stochastic Oscillator 54.44 81.09

Price Performance

Historical Comparison
ESPR
CCNE

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.

About CCNE CNB Financial Corporation

CNB Financial Corp is a Pennsylvania-chartered bank. The bank is a full-service bank engaging in a full range of banking activities and services for individual, business, governmental and institutional customers. These activities and services principally include checking, savings, and time deposit accounts; real estate, commercial, industrial, residential and consumer loans; and a variety of other specialized financial services. Its Private Client Solutions division offers a full range of client services, including private banking and wealth and asset management. The banking segment derives its revenue through the operations as a full-service bank services, including trust and wealth management services, for individual, business, governmental, and institutional customers.

Share on Social Networks: